National new and special drug Fair: how can new drugs be "left over"

From July 26 to 28, the 48th national new special drugs fair was held in Suzhou Pharmaceutical enterprises from home and abroad, pharmaceutical agents, distributors, drugstore purchasers, pharmaceutical R & D personnel, industry experts and professional visitors attended the fair The reporter interviewed several exhibitors and professional audiences at random, obviously feeling their desire for new drugs "At present, the domestic pharmaceutical environment is full of too much uncertainty, and the industry chain with pressure on the back and belly forces us to look for the reason of" remaining ", especially with the early harvest of new drug research and development, many new products have been approved recently, who can compete for high-quality new varieties with unique clinical characteristics, who can capture new opportunities in the increasingly international market of local competition ”Mr Huang, a pharmaceutical agent in Shanghai, told reporters New drugs sink in the meeting site Although the representatives are looking for their own "it", from these exhibits, the reporter noted that many enterprises are still exhibiting traditional brand products, and there are not many truly innovative new products An agent from Chengdu complained to reporters: "the innovation environment of the pharmaceutical industry is not ideal, and it is really difficult to find new drugs with excellent quality." Even if there is a new product, he is uncertain He holds a newly approved anti lung cancer innovative product of an enterprise in Shenzhen Now, the reform trend of drug price, medical insurance, bidding and so on is not clear, and the new product listing needs to do a lot of preparations for market access In the conference hall, some exhibitors said that agents have a strong desire to acquire new products, but the current industrial environment makes them have some wait-and-see mood Nowadays, the policy of encouraging new drugs is constantly increasing, and the quality consistency evaluation of generic drugs is also in full swing If there is no real high-quality new varieties in hand in the future, many enterprises will only go narrower, which is the consensus of many participants "The competition of high-quality varieties will become the mainstream competition mode in the future, although the R & D input-output ratio of new drugs is constantly improving, domestic representative enterprises such as ours, which mainly focus on innovation, will also look for some good varieties with potential from outside, after all, no one will miss the release of basic drug market." While looking for new products, expanding the basic market has become a well deserved hot spot Mr Zhang, from Guangdong, said frankly that in March this year, the state released a new version of the national drug base catalogue in 2012, expanding the capacity from 307 to 520 The seemingly booming market for basic drugs is still far from settled There is no doubt that the basic drug supplement program launched successively in Guangdong and Qinghai has not been broken For the dealers and purchasers who are eager to open up the market, the key to them is to find products with high cost performance Li Changming, an expert of the national medical reform expert committee, pointed out at the meeting: "the policy intersection of the implementation plan of medical reform is at the grass-roots level From the perspective of the new rural cooperative medical system, the government's investment in this project has increased from yuan in 2003 to yuan in 2013, which shows that the flow of medical resources will certainly guide the sales flow of pharmaceutical enterprises, and new drugs and basic drug varieties will appear in the grass-roots medical market The pattern of drug use " He said that as for which varieties will benefit preferentially and which areas will increase the use of drugs, it mainly depends on the clinical varieties who sink deeply and whose service is better Although there are difficulties in the domestic primary medical market under new drugs, no one in the industry is willing to give up In the "second seminar on primary medical market and enterprise development strategy" held during the fair, many managers of new drug enterprises crowded into the conference room to reflect the inner expression of the industry To realize the value of the whole chain is different from the previous new special drug fair This fair will be jointly exhibited with the 2013 China drugstore purchase and supply Expo, the 14th National Medical Equipment regional Expo, green hospital solutions Expo and other exhibitions for the first time, attracting representatives of the whole industry chain to attend the fair This is exactly where many pharmaceutical enterprises are constrained in the process of market expansion In recent years, most pharmaceutical enterprises in China are faced with the problems of customer fragmentation and regional decentralization when they conduct channel investment, while drugstores are also faced with the problems of wide comparison and multi regional communication when purchasing products Although there are various platforms, it is still impossible to avoid the intensive work of audition partners "The significance of the exhibition now lies more in promoting the deep integration and intercommunication of the industry," Mr Huang told reporters "The joint efforts of six exhibitions have effectively promoted the business docking between drugstores and suppliers, and created a good negotiation environment for drugstores and suppliers." It is reported that there are more than 200 suppliers of health products, dietary supplements, health food and health drinks, nearly 100 suppliers of cosmetics and daily necessities such as functional cosmetics, as well as suppliers of mother and infant products, traditional Chinese medicine and herbal pieces, which are convenient for dealers and purchasers to conduct centralized negotiation and purchase of diversified products In addition, it is worth mentioning that the 2013 China pharmacy procurement conference realized the on-site negotiation and procurement of diversified commodity suppliers The policy of encouraging new drugs is constantly increasing, and the quality consistency evaluation of generic drugs is also in full swing If there is no real high-quality new varieties in hand in the future, many enterprises will only go narrower, which is the consensus of many participants For dealers and purchasers who are eager to explore the market, the key to them is to find products with high cost performance.